There were approximately 6 million orthopedic surgeries performed in 2019 at a cost of over 10 billion dollars. Recovery from these surgeries generally takes months. Most people agree that they would rather have surgery as a last resort; however, in the United States, it is often recommended as the first course of action.
Thanks to advances in science and technology, a modern solution has emerged that does not involve surgery or the recovery time that comes with it. The solution is Human Cellular Tissue Product (HCTP); the future of medicine is here today. Owing to 20+ years of research and scientific progress, what was once available only to movie stars and professional athletes is now available to everyone.
What are Human Cellular Tissue Product (HCTP) Injections?
HCTP is a unique approach to healthcare that aims to help the human body repair, reconstruct, replace, or regenerate its own tissues and organs to restore healthy, natural function.
How can HCTP Injections help me?
Aging and normal wear slowly degenerates the tissues in the body, including muscles, tendons, ligaments, nerves, and cartilage. These changes can be sped up by injuries, falls, and disease states, such as arthritis, cancer, diabetes, inflammation, and poor nutrition. HCTP Injections can support the body in healing its own damaged tissue without the need for surgeries, dependence on medications or walking aids, and tolerance of daily pain. Tissue can be regrown to be strong and fully functional in highly used areas of the body – namely, the spine, hips, shoulders, knees, ankles, and other large joints. Whether the goal is to walk the aisles in the grocery store, or to run a 100 mile race, HCTP Injections can serve to both facilitate and accelerate the recovery process.
How do HCTP Injections work?
HCTP Injections work by utilizing human cells or tissues to assist the body in its own healing process. These human cells and tissue products come from either your own body, or are donated from the umbilical cord of a healthy mother after she has a healthy baby. The mesenchymal stromal cells that are derived from umbilical cords do not contain any fetal or embryonic tissue, and they are obtained under strict ethical protocols with informed consent. Donated mesenchymal stem cells are interchangeable with adult stem cells, with the added benefit of being “younger”; therefore, they are rich in growth factors, have a better survival rate, and show greater effectiveness. Elevate Medical is continuously reviewing the research and maintains the highest standards when selecting its source for umbilical cord tissue.
Are there side effects or a recovery period?
Side effects are uncommon. After administration, there may be some discomfort or increased sensitivity at the site of injection. If the original problem involved numbness due to nerve damage, a temporary increase in nerve sensation can sometimes be perceived as a side effect. Light activities may be recommended for a day or two; however, this is usually the extent of restriction or necessary recovery period.
How long to see results?
Signs of improvement are typically noticeable within the first 6-8 weeks, particularly with Protein Rich Plasma Therapy. Mesenchymal stromal cells remain active in the body for up to six months, with symptom improvement most notable between 3-6 months. Compliance to the supportive therapies in Elevate Medical’s HCTP Injection Program, including a targeted nutrition protocol, electrical stimulation, ultrasound therapy, and rehabilitation, assist with speeding up this process and producing higher quality results.
Why choose Elevate Medical for HCTP Injections?
The providers at Elevate Medical have specialized training in the field of mesenchymal stromal cell treatment. Utilizing a specific combination of HCTP Injections, Protein Rich Plasma Injections, HakoMed Bioelectric Therapy, and Mediwave Ultrasound Shock Therapy, in conjunction with a collaborative, multi-disciplinary approach, profound results are achieved without the need for invasive surgery or reliance on drugs.